Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

French group patents K(2P)2.1 activators for pain

July 22, 2013

Eisai reports first clinical data for anti-protofibrilar monoclonal antibody BAN-2401

July 22, 2013

Phase I results demonstrate intravenous LBR-101 to be safe and well tolerated

July 22, 2013

Phase III study of Spinal Restoration's Biostat System for low back pain misses primary endpoint

July 19, 2013

Cooperative phase IIb trial of MediciNova's MN-166 begins in patients with progressive MS

July 19, 2013

EMA committee recommends orphan drug status for Soliris in rare neurological disease

July 19, 2013

Noscira presents results from the ARGO trial of tideglusib

July 19, 2013

Preliminary data presented for the anti-protofibrillar Abeta MAb SAR-228810

July 19, 2013

Osthole-derived compound has beneficial effects on learning and memory

July 19, 2013

Recruitment begins in Boehringer Ingelheim's phase I trial of BI-409306

July 18, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...